Redefining tissue engineering for nanomedicine in ophthalmology

Area of Science:

• Ophthalmology
• Nanomedicine
• Tissue Engineering

Background:

• Working at the nanoscale requires rethinking traditional engineering approaches, especially for ocular applications.
• Nanomedicine enables influencing biological environments through additive (replacement/growth) or arrestive (inhibiting aberrant growth) tissue engineering strategies.
• The goal is to optimize or restore tissue function by manipulating the local environment.

Purpose of the Study:

• To review the applications of nanoscale tissue engineering in influencing the local ocular environment.
• To explore how nanomedicine can be used for both additive and arrestive tissue engineering in ophthalmology.
• To highlight future directions in nanoscale interventions for eye conditions.

Main Methods:

• Review of current nanomedicine and tissue engineering strategies.
• Discussion of additive approaches like cell transplantation and scaffold creation.
• Exploration of arrestive therapies, including gene-related treatments.

Main Results:

• Nanoscale manipulation allows control over healing rates and distribution.
• Potential applications include corneal endothelial cell transplantation, retinal cell repair, and nanofiber scaffold development for axonal regeneration.
• Ocular drug delivery is a key area of application.
• Arrestive therapies can inhibit intraocular neovascularization and block retinal cell apoptosis.

Conclusions:

• Nanoscale tissue engineering holds significant promise for advancing ophthalmology.
• It offers precise control over the ocular environment for therapeutic interventions.
• Future research will continue to leverage nanoscale approaches for eye repair and regeneration.